Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 516

1.

Serum Creatinine Levels Before, During, and After Pregnancy.

Harel Z, McArthur E, Hladunewich M, Dirk JS, Wald R, Garg AX, Ray JG.

JAMA. 2019 Jan 15;321(2):205-207. doi: 10.1001/jama.2018.17948. No abstract available.

PMID:
30644975
2.

Clinical Outcomes of Failing to Dose-Reduce Cephalosporin Antibiotics in Older Adults with CKD.

Bathini L, Jandoc R, Kuwornu P, McArthur E, Weir MA, Sood MM, Battistella M, Muanda FT, Liu A, Jain AK, Garg AX.

Clin J Am Soc Nephrol. 2019 Jan 10. pii: CJN.10710918. doi: 10.2215/CJN.10710918. [Epub ahead of print]

PMID:
30630861
3.

Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1: Study Protocol for a Multicenter Clinical Trial.

Weir MA, Walsh M, Cuerden MS, Sontrop JM, Chambers LC, Garg AX.

Can J Kidney Health Dis. 2018 Dec 5;5:2054358118813088. doi: 10.1177/2054358118813088. eCollection 2018.

4.

Survival of patients with subglottic squamous cell carcinoma.

MacNeil SD, Patel K, Liu K, Shariff S, Yoo J, Nichols A, Fung K, Garg AX.

Curr Oncol. 2018 Dec;25(6):e569-e575. doi: 10.3747/co.25.3864. Epub 2018 Dec 1.

5.

Blood Lithium Monitoring Practices in a Population-Based Sample of Older Adults.

Rej S, Herrmann N, Gruneir A, Jandoc R, McArthur E, Dixon S, Garg AX.

J Clin Psychiatry. 2018 Nov 20;79(6). pii: 17m12095. doi: 10.4088/JCP.17m12095.

6.

Population-Based Study of Risk of AKI with Levetiracetam.

Yau K, Burneo JG, Jandoc R, McArthur E, Muanda FT, Parikh CR, Wald R, Weir MA, Garg AX.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):17-26. doi: 10.2215/CJN.07490618. Epub 2018 Dec 11.

PMID:
30538089
7.

The Association of Kidney Function and Albuminuria With the Risk and Outcomes of Syncope: A Population-Based Cohort Study.

Massicotte-Azarniouch D, Kuwornu JP, McCallum MK, Bansal N, Lam N, Molnar AO, Pun P, Zimmerman D, Garg AX, Sood MM.

Can J Cardiol. 2018 Dec;34(12):1631-1640. doi: 10.1016/j.cjca.2018.08.033. Epub 2018 Aug 28.

PMID:
30527152
8.
9.

The Efficiency of Evaluating Candidates for Living Kidney Donation: A Scoping Review.

Habbous S, Woo J, Lam NN, Lentine KL, Cooper M, Reich M, Garg AX.

Transplant Direct. 2018 Sep 20;4(10):e394. doi: 10.1097/TXD.0000000000000833. eCollection 2018 Oct.

10.

A retrospective population-based cohort study to evaluate the impact of an older sibling with undescended testis and hypospadias on the known maternal and fetal risk factors for undescended testis and hypospadias in Ontario, Canada, 1997-2007.

Dave S, Liu K, Clark R, Garg AX, Shariff SZ.

J Pediatr Urol. 2018 Oct 10. pii: S1477-5131(18)30604-1. doi: 10.1016/j.jpurol.2018.09.021. [Epub ahead of print]

PMID:
30459092
11.

Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.

Kitchlu A, McArthur E, Amir E, Booth CM, Sutradhar R, Majeed H, Nash DM, Silver SA, Garg AX, Chan CT, Kim SJ, Wald R.

J Natl Cancer Inst. 2018 Nov 13. doi: 10.1093/jnci/djy167. [Epub ahead of print]

PMID:
30423160
12.

Financial Costs Incurred by Living Kidney Donors: A Prospective Cohort Study.

Przech S, Garg AX, Arnold JB, Barnieh L, Cuerden MS, Dipchand C, Feldman L, Gill JS, Karpinski M, Knoll G, Lok C, Miller M, Monroy M, Nguan C, Prasad GVR, Sarma S, Sontrop JM, Storsley L, Klarenbach S; Donor Nephrectomy Outcomes Research (DONOR) Network.

J Am Soc Nephrol. 2018 Dec;29(12):2847-2857. doi: 10.1681/ASN.2018040398. Epub 2018 Nov 7.

PMID:
30404908
13.

Patient and caregiver involvement in a multicentre clustered hemodialysis trial.

Ward JM, Getchell L, Garg AX; MyTEMP Investigators.

CMAJ. 2018 Nov 7;190(Suppl):S32-S33. doi: 10.1503/cmaj.180403. No abstract available.

PMID:
30404848
14.

Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial.

Garg AX, Devereaux PJ, Hill A, Sood M, Aggarwal B, Dubois L, Hiremath S, Guzman R, Iyer V, James M, McArthur E, Moist L, Ouellet G, Parikh CR, Schumann V, Sharan S, Thiessen-Philbrook H, Tobe S, Wald R, Walsh M, Weir M, Pannu N; Curcumin AAA AKI Investigators.

CMAJ. 2018 Oct 29;190(43):E1273-E1280. doi: 10.1503/cmaj.180510. Erratum in: CMAJ. 2018 Dec 3;190(48):E1425.

15.

Comparing Five Comorbidity Indices to Predict Mortality in Chronic Kidney Disease: A Retrospective Cohort Study.

McArthur E, Bota SE, Sood MM, Nesrallah GE, Kim SJ, Garg AX, Dixon SN.

Can J Kidney Health Dis. 2018 Oct 15;5:2054358118805418. doi: 10.1177/2054358118805418. eCollection 2018.

16.

Predicting 3-Year Survival in Patients Receiving Maintenance Dialysis: An External Validation of iChoose Kidney in Ontario, Canada.

Tan VS, Garg AX, McArthur E, Patzer RE, Gander J, Roshanov P, Kim SJ, Knoll GA, Yohanna S, McCallum MK, Naylor KL.

Can J Kidney Health Dis. 2018 Oct 4;5:2054358118799693. doi: 10.1177/2054358118799693. eCollection 2018.

17.

The Health and Health Care of Adults With Type 1 And 2 Diabetes Across the Spectrum of Estimated Glomerular Filtration Rates.

Clemens KK, Ouédraogo A, Nash DM, Garg AX, Shariff SZ.

Can J Diabetes. 2018 Jun 21. pii: S1499-2671(18)30148-5. doi: 10.1016/j.jcjd.2018.06.005. [Epub ahead of print]

PMID:
30287054
18.

Hospital case volume and clinical outcomes in critically ill patients with acute kidney injury treated with dialysis.

Chimunda T, Silver SA, Kuwornu JP, Li L, Nash DM, Dixon SN, Adhikari NKJ, Acedillo RR, Harel Z, Kitchlu A, Garg AX, Bell CM, Sood MM, Kim JS, Wald R.

J Crit Care. 2018 Dec;48:276-282. doi: 10.1016/j.jcrc.2018.08.024. Epub 2018 Sep 5.

PMID:
30248649
19.

Socioeconomic Status and Kidney Transplant Outcomes in a Universal Healthcare System: A Population-based Cohort Study.

Naylor KL, Knoll GA, Shariff SZ, McArthur E, Garg AX, Van Walraven C, Austin PC, McCallum MK, Quinn RR, Tan VS, Kim JS.

Transplantation. 2018 Sep 21. doi: 10.1097/TP.0000000000002383. [Epub ahead of print]

PMID:
30247444
20.

A matched case-control study to assess the association between non-steroidal anti-inflammatory drug use and thrombotic microangiopathy.

Liu AR, Hildebrand AM, Dixon S, Sontrop JM, Clark WF, Lazo-Langner A, Nash D, Garg AX.

PLoS One. 2018 Aug 24;13(8):e0202801. doi: 10.1371/journal.pone.0202801. eCollection 2018.

21.

Outcomes of the First and Second Hemodialysis Fistula: A Cohort Study.

Kamar F, Quinn RR, Oliver MJ, Viecelli AK, Hiremath S, MacRae J, Miller L, Blake P, Moist L, Garg AX, Lam NN, Kabani R, Clarke A, Liu P, Gillespie B, Ravani P.

Am J Kidney Dis. 2019 Jan;73(1):62-71. doi: 10.1053/j.ajkd.2018.06.007. Epub 2018 Aug 16.

PMID:
30122545
22.

Utility of Biomarkers to Improve Prediction of Readmission or Mortality After Cardiac Surgery.

Brown JR, Jacobs JP, Alam SS, Thiessen-Philbrook H, Everett A, Likosky DS, Lobdell K, Wyler von Ballmoos MC, Parker DM, Garg AX, Mackenzie T, Jacobs ML, Parikh CR.

Ann Thorac Surg. 2018 Nov;106(5):1294-1301. doi: 10.1016/j.athoracsur.2018.06.052. Epub 2018 Aug 4.

PMID:
30086283
23.

Is the Kidney Donor Risk Index a Useful Tool in Non-US Patients?

Young A, Knoll GA, McArthur E, Dixon SN, Garg AX, Lok CE, Lam NN, Kim SJ.

Can J Kidney Health Dis. 2018 Jul 27;5:2054358118791148. doi: 10.1177/2054358118791148. eCollection 2018.

24.

Follow-up Care of Living Kidney Donors in Alberta, Canada.

Lam NN, Lentine KL, Hemmelgarn B, Klarenbach S, Quinn RR, Lloyd A, Gourishankar S, Garg AX.

Can J Kidney Health Dis. 2018 Jul 26;5:2054358118789366. doi: 10.1177/2054358118789366. eCollection 2018.

25.

Home Palliative Service Utilization and Care Trajectory Among Ontario Residents Dying on Chronic Dialysis.

Nesrallah GE, Dixon SN, MacKinnon M, Jassal SV, Bota SE, Dirk JS, Arthurs E, Blake PG, Sood MM, Garg AX, Davison SN.

Can J Kidney Health Dis. 2018 Jul 24;5:2054358118783761. doi: 10.1177/2054358118783761. eCollection 2018.

26.

Helping More Patients Receive a Living Donor Kidney Transplant.

Garg AX.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1918-1923. doi: 10.2215/CJN.00760118. Epub 2018 Aug 6.

PMID:
30082336
27.

Secular trends in the incidence and timing of surgical intervention for congenital undescended testis and surgically treated hypospadias in Ontario, Canada between 1997 and 2007.

Dave S, Liu K, Garg AX, Shariff SZ.

J Pediatr Urol. 2018 Dec;14(6):552.e1-552.e7. doi: 10.1016/j.jpurol.2018.07.003. Epub 2018 Jul 24.

PMID:
30072120
28.

Immigration, region of origin, and the epidemiology of venous thromboembolism: A population-based study.

Lazo-Langner A, Liu K, Shariff S, Garg AX, Ray JG.

Res Pract Thromb Haemost. 2018 May 27;2(3):469-480. doi: 10.1002/rth2.12113. eCollection 2018 Jul.

29.

Healthcare Costs for the Evaluation, Surgery, and Follow-Up Care of Living Kidney Donors.

Habbous S, Sarma S, Barnieh LJ, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Aug;102(8):1367-1374. doi: 10.1097/TP.0000000000002222.

PMID:
30044364
30.

Thiazide Diuretic Dose and Risk of Kidney Stones in Older Adults: A Retrospective Cohort Study.

Alexander RT, McArthur E, Jandoc R, Welk B, Fuster DG, Garg AX, Quinn RR.

Can J Kidney Health Dis. 2018 Jul 15;5:2054358118787480. doi: 10.1177/2054358118787480. eCollection 2018.

31.

Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery.

Polineni S, Parker DM, Alam SS, Thiessen-Philbrook H, McArthur E, DiScipio AW, Malenka DJ, Parikh CR, Garg AX, Brown JR.

J Am Heart Assoc. 2018 Jul 7;7(14). pii: e008371. doi: 10.1161/JAHA.117.008371.

32.

Representation of Patients With Chronic Kidney Disease in Trials of Cancer Therapy.

Kitchlu A, Shapiro J, Amir E, Garg AX, Kim SJ, Wald R, Harel Z.

JAMA. 2018 Jun 19;319(23):2437-2439. doi: 10.1001/jama.2018.7260. No abstract available.

PMID:
29922818
33.

Identifying Outcomes that Are Important to Living Kidney Donors: A Nominal Group Technique Study.

Hanson CS, Chapman JR, Gill JS, Kanellis J, Wong G, Craig JC, Teixeira-Pinto A, Chadban SJ, Garg AX, Ralph AF, Pinter J, Lewis JR, Tong A.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):916-926. doi: 10.2215/CJN.13441217. Epub 2018 May 31.

PMID:
29853616
34.

Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: The CKD WIT Randomized Clinical Trial.

Clark WF, Sontrop JM, Huang SH, Gallo K, Moist L, House AA, Cuerden MS, Weir MA, Bagga A, Brimble S, Burke A, Muirhead N, Pandeya S, Garg AX.

JAMA. 2018 May 8;319(18):1870-1879. doi: 10.1001/jama.2018.4930.

PMID:
29801012
35.

ESRD among Immigrants to Ontario, Canada: A Population-Based Study.

Perl J, McArthur E, Tan VS, Nash DM, Garg AX, Harel Z, Li AH, Sood MM, Ray JG, Wald R.

J Am Soc Nephrol. 2018 Jul;29(7):1948-1959. doi: 10.1681/ASN.2017101055. Epub 2018 May 2.

PMID:
29720548
36.

Health care costs for the evaluation, surgery, and follow-up care of living kidney donors.

Habbous S, Sarma S, Barnieh L, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002222. [Epub ahead of print]

PMID:
29677068
37.

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline.

Lentine KL, Levey AS, Garg AX; KDIGO Living Kidney Donor Work Group.

Am J Kidney Dis. 2018 Jul;72(1):154-155. doi: 10.1053/j.ajkd.2018.01.059. Epub 2018 Apr 16. No abstract available.

PMID:
29673725
38.

Nephrology comanagement and the quality of antibiotic prescribing in primary care for patients with chronic kidney disease: a retrospective cross-sectional study.

Zhu JXG, Nash DM, McArthur E, Farag A, Garg AX, Jain AK.

Nephrol Dial Transplant. 2018 Apr 12. doi: 10.1093/ndt/gfy072. [Epub ahead of print]

PMID:
29669046
39.

Validation of Living Donor Nephrectomy Codes.

Lam NN, Lentine KL, Klarenbach S, Sood MM, Kuwornu PJ, Naylor KL, Knoll GA, Kim SJ, Young A, Garg AX.

Can J Kidney Health Dis. 2018 Apr 9;5:2054358118760833. doi: 10.1177/2054358118760833. eCollection 2018.

40.

Identification of Patients Expected to Benefit from Electronic Alerts for Acute Kidney Injury.

Biswas A, Parikh CR, Feldman HI, Garg AX, Latham S, Lin H, Palevsky PM, Ugwuowo U, Wilson FP.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):842-849. doi: 10.2215/CJN.13351217. Epub 2018 Mar 29.

PMID:
29599299
41.

Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies.

Habbous S, Arnold J, Begen MA, Boudville N, Cooper M, Dipchand C, Dixon SN, Feldman LS, Goździk D, Karpinski M, Klarenbach S, Knoll GA, Lam NN, Lentine KL, Lok C, McArthur E, McKenzie S, Miller M, Monroy-Cuadros M, Nguan C, Prasad GVR, Przech S, Sarma S, Segev DL, Storsley L, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Kidney Dis. 2018 Oct;72(4):483-498. doi: 10.1053/j.ajkd.2018.01.036. Epub 2018 Mar 24.

42.

Potential implications of a more timely living kidney donor evaluation.

Habbous S, McArthur E, Sarma S, Begen MA, Lam NN, Manns B, Lentine KL, Dipchand C, Litchfield K, McKenzie S, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Transplant. 2018 Nov;18(11):2719-2729. doi: 10.1111/ajt.14732. Epub 2018 Apr 17.

PMID:
29575655
43.

A Province-wide, Cross-sectional Study of Demographics and Medication Use of Patients in Hemodialysis Units Across Ontario.

Battistella M, Jandoc R, Ng JY, McArthur E, Garg AX.

Can J Kidney Health Dis. 2018 Mar 13;5:2054358118760832. doi: 10.1177/2054358118760832. eCollection 2018.

44.

Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease.

Habbous S, Przech S, Martin J, Garg AX, Sarma S.

Value Health. 2018 Mar;21(3):318-325. doi: 10.1016/j.jval.2017.08.3020. Epub 2017 Oct 18.

PMID:
29566839
45.

Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study.

Fleet JL, Dixon SN, Kuwornu PJ, Dev VK, Montero-Odasso M, Burneo J, Garg AX.

PLoS One. 2018 Mar 14;13(3):e0193134. doi: 10.1371/journal.pone.0193134. eCollection 2018.

46.

Initiating Maintenance Dialysis Before Living Kidney Donor Transplantation When a Donor Candidate Evaluation Is Well Underway.

Habbous S, McArthur E, Dixon SN, McKenzie S, Garcia-Ochoa C, Lam NN, Lentine KL, Dipchand C, Litchfield K, Begen MA, Sarma S, Garg AX.

Transplantation. 2018 Jul;102(7):e345-e353. doi: 10.1097/TP.0000000000002159.

PMID:
29538259
47.

Validity of administrative database code algorithms to identify vascular access placement, surgical revisions, and secondary patency.

Al-Jaishi AA, Moist LM, Oliver MJ, Nash DM, Fleet JL, Garg AX, Lok CE.

J Vasc Access. 2018 Nov;19(6):561-568. doi: 10.1177/1129729818762008. Epub 2018 Mar 12.

PMID:
29529926
48.

Association between Duration of Predialysis Care and Mortality after Dialysis Start.

Liu P, Quinn RR, Oliver MJ, Ronksley PE, Hemmelgarn BR, Quan H, Hiremath S, Bello AK, Blake PG, Garg AX, Johnson J, Verrelli M, Zacharias JM, Abd ElHafeez S, Tonelli M, Ravani P.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):893-899. doi: 10.2215/CJN.11951017. Epub 2018 Mar 5.

PMID:
29507006
49.

Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function.

Levin A, Adams E, Barrett BJ, Beanlands H, Burns KD, Chiu HH, Chong K, Dart A, Ferera J, Fernandez N, Fowler E, Garg AX, Gilbert R, Harris H, Harvey R, Hemmelgarn B, James M, Johnson J, Kappel J, Komenda P, McCormick M, McIntyre C, Mahmud F, Pei Y, Pollock G, Reich H, Rosenblum ND, Scholey J, Sochett E, Tang M, Tangri N, Tonelli M, Turner C, Walsh M, Woods C, Manns B.

Can J Kidney Health Dis. 2018 Jan 17;5:2054358117749530. doi: 10.1177/2054358117749530. eCollection 2018.

50.

Risk of rhabdomyolysis from 5-α reductase inhibitors.

Welk B, McArthur E, Ordon M, Dirk J, Dixon S, Garg AX.

Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):351-355. doi: 10.1002/pds.4383. Epub 2018 Jan 25.

PMID:
29368380

Supplemental Content

Support Center